Gary H. Lyman on the Immediate and Long-Term Effects of Febrile Neutropenia

Video

Gary H. Lyman, MD, MPH, Fred Hutchinson Cancer Research Center, discusses the immediate and long-term effects of febrile neutropenia.

Gary H. Lyman, MD, MPH, Fred Hutchinson Cancer Research Center, discusses the immediate and long-term effects of febrile neutropenia.

A study presented at the 2016 ASCO Annual Meeting showed that patients with early-stage breast cancer who experience febrile neutropenia as a result of chemotherapy usually get a reduced relative dose intensity (RDI) for their chemotherapy. Although this usually helps the febrile neutropenia, it often has negative effects down the line, Lyman says.

Modifying or reducing a patient’s chemotherapy dosage has a dramatic effect on the cure and long-term survival rates because of a higher rate of disease recurrence.

Recent Videos
Image of a woman with glasses wearing a striped blouse and a black sweater in front of an Oncology Nursing News branded backdrop
Screenshot of Kiah Purcell, MSN, AGPCNP-BC, in a video call with the frame surrounded by an Oncology Nursing News branded border
Photo of Jamie Carroll, APRN, CNP, MSN, from a video call with an Oncology Nursing News branded border around the frame
5 experts in this video
Image of Kayle Freeman, DNP, APRN, FNP-C, in a video call with an Oncology Nursing News border around the frame
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
Related Content